دورية أكاديمية

Estimated Life-Years Saved in Women with HER2-Positive Metastatic Breast Cancer Receiving First-Line Trastuzumab and Pertuzumab in the United States

التفاصيل البيبلوغرافية
العنوان: Estimated Life-Years Saved in Women with HER2-Positive Metastatic Breast Cancer Receiving First-Line Trastuzumab and Pertuzumab in the United States
المؤلفون: Danese, Mark D., Masaquel, Anthony, Santos, Eduardo, Brammer, Melissa, Lee, Abraham, Lalla, Deepa
المصدر: In Value in Health September 2015 18(6):876-883
قاعدة البيانات: ScienceDirect
الوصف
تدمد:10983015
DOI:10.1016/j.jval.2015.06.003